Previous 10 | Next 10 |
2023-10-31 09:01:16 ET More on Thermo Fisher Scientific Thermo Fisher Scientific: Too Big For Olink To Move The Needle Thermo Fisher Scientific: Transforming Healthcare Leadership Post-COVID-19 Pandemic Thermo Fisher drags peers after Q3 miss; Wells Fargo upgrades ...
2023-10-29 17:28:12 ET More on Guardant Health, Natera, etc. Natera: Cash Burn Remains A Concern Guardant Health: Peeling Back Economic Layers, Compressed Market Values Appear Justified Pacific Biosciences: Looks Appealing In The Fast-Growing Long-Read Sequencing Mar...
2023-10-18 08:59:44 ET Summary Thermo Fisher is paying a high price for Olink, but its size relative to the overall company is not big enough to significantly affect Thermo's valuation. With little upside from current prices to the deal value of $26 per share, OLK stock is now a s...
2023-10-17 11:29:41 ET Shares of Olink Holding AB (NASDAQ: OLK) are skyrocketing 66.1% higher as of 11 a.m. ET on Tuesday. The huge jump came after Thermo Fisher Scientific (NYSE: TMO) announced plans to acquire Olink for roughly $3.1 billion in an all-cash transaction. ...
2023-10-17 08:42:30 ET More on Thermo Fisher Scientific Thermo Fisher Scientific: Transforming Healthcare Leadership Post-COVID-19 Pandemic Thermo Fisher: I'm Waiting For A Better Valuation In This High-Quality Business Thermo Fisher: An Up To 35% Undervalued Healthc...
Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions Complements Existing Life Sciences and Mass Spectrometry Offerings, Accelerating Protein Biomarker Discovery and Providing Strong Synergy Opportunities ...
UPPSALA, Sweden, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today reported the publication of three articles in the prestigious scientific journal, Nature , that demonstrate the power of the Olink Explore platform for driving impactful proteogenomic studies at the...
Uppsala, Sweden, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Announcing the Olink ® Target 48 Mouse Cytokine Panel – the n ext g eneration in i mmunoassays desi gned to accelerate translational research. Discover more ...
Uppsala, Sweden, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Eurofins Genomics a dopts Olink ® technology to advance proteomics research and accelerate precision medicine programs UPPSALA, Sweden, 12 th September, 2023 (GLOBE NEWSWIRE) -- Olink ...
UPPSALA, Sweden, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor events: Goldman Sachs 20 th Annual European Medtech and Healthcare Services Co...
News, Short Squeeze, Breakout and More Instantly...
Olink Holding AB (publ) Company Name:
OLK Stock Symbol:
NASDAQ Market:
Olink Holding AB (publ) Website:
Subsequent Offering Period Scheduled to Expire at 5:00 p.m., New York Time, on July 16, 2024 Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed its acquisition of Olink Holding AB (publ) (...
UPPSALA, Sweden, July 08, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the UK Competition and Markets Authority (the “CMA”) has unconditionally approved the previously announced tender offer (the “Offer”) b...
UPPSALA, Sweden, July 05, 2024 (GLOBE NEWSWIRE) -- At the Extra General Meeting (the “EGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), the EGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents ...